GPIIB/IIIA ANTAGONISTS WITH LONG ORAL DURATION

被引：0

作者：

SAMANEN, J ^{[1
]}

ALI, F ^{[1
]}

BARTON, L ^{[1
]}

BONDINELL, W ^{[1
]}

BURGESS, J ^{[1
]}

CALLAHAN, J ^{[1
]}

CALVO, R ^{[1
]}

CHEN, L ^{[1
]}

ERHARD, K ^{[1
]}

HWANG, SM ^{[1
]}

JAKAS, D ^{[1
]}

KEENAN, R ^{[1
]}

KU, T ^{[1
]}

KWON, C ^{[1
]}

LEE, CP ^{[1
]}

MILLER, W ^{[1
]}

NEWLANDER, K ^{[1
]}

NICHOLS, A ^{[1
]}

PARKER, M ^{[1
]}

PEISHOFF, C ^{[1
]}

RHODES, G ^{[1
]}

ROSS, S ^{[1
]}

SIMPSON, R ^{[1
]}

TAKATA, D ^{[1
]}

YELLIN, TO ^{[1
]}

UZSINSKAS, I ^{[1
]}

VENSLAVSKY, J ^{[1
]}

YUAN, CY ^{[1
]}

HUFFMAN, W ^{[1
]}

机构：

[1] SMITHKLINE BEECHAM PHARMACEUT,KING OF PRUSSIA,PA 19406

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1995年 / 209卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页码：237 / MEDI

共 50 条

[41] PLATELET GPIIB/IIIA ANTAGONISTS IN THE CANINE ARTERIOVENOUS SHUNT - POTENTIAL THROMBUS IMAGING AGENTS
BARRETT, JA
HEMINWAY, S
DAMPHOUSSE, D
THOMAS, J
LOOBY, R
EDWARDS, S
HARRIS, T
RAJOPADHYE, M
LIU, S
CARROLL, T
JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (05) : P52 - P52
[42] Differential antiplatelet efficacy for various GPIIb/IIIa antagonists: Role of plasma calcium levels
Mousa, SA
Bozarth, JM
Forsythe, MS
Slee, A
CARDIOVASCULAR RESEARCH, 2000, 47 (04) : 819 - 826
[43] DESIGN AND EVALUATION OF NONPEPTIDE FIBRINOGEN GAMMA-CHAIN BASED GPIIB/IIIA ANTAGONISTS
HOEKSTRA, WJ
BEAVERS, MP
ANDRADEGORDON, P
EVANGELISTO, MF
KEANE, PM
PRESS, JB
TOMKO, KA
FAN, F
KLOCZEWIAK, M
MAYO, KH
DURKIN, KA
LIOTTA, DC
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (10) : 1582 - 1592
[44] Elevating local concentrations of GPIIb-IIIa antagonists counteracts platelet thrombus stability
Speich, Henry E.
Furman, Ronit R.
Lands, Lindsey T.
Moodie, Geoffrey D.
Jennings, Lisa K.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2013, 36 (01) : 31 - 41
[45] The anti-GPIIb-IIIa
Nurden, P
TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2001, 8 (02) : 114 - 122
[46] SEPARATION OF GLYCOPROTEIN IIB/IIIA (GPIIB/IIIA) MULTIMER AND GPIIB/IIIA COMPLEXED WITH FIBRINOGEN BY MEANS OF SIZE EXCLUSION HPLC
NORTON, K
NIEWIAROWSKI, S
FASEB JOURNAL, 1988, 2 (04): : A399 - A399
[47] Recombinant anti-GPIIb/IIIa autoantibodies inhibit binding of fibrinogen to GPIIb/IIIa.
Escher, R
Vogel, M
Miescher, S
Stadler, BM
Berchtold, P
BLOOD, 1999, 94 (10) : 450A - 450A
[48] Prevention of carotid artery thrombosis by oral platelet GPIIb/IIIa antagonist in dogs
Mousa, SA
Mu, DX
Lucchesi, BR
STROKE, 1997, 28 (04) : 830 - 835
[49] Effect of antagonists on GPIIb/IIIa receptor occupancy: use of a whole blood flow cytometry assay
Besson, I
McGregor, JL
THROMBOSIS AND HAEMOSTASIS, 1997, : P2711 - P2711
[50] UR-3216: A new generation oral platelet GPIIb/IIIa antagonist
Aga, Y
Baba, K
Tam, S
Nakanishi, T
Yoneda, K
Kita, J
Ueno, H
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (14) : 1597 - 1601

← 1 2 3 4 5 →